Avidity Biosci Rg
RNA
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
08/30/2025 - 02:00:00
Bid
08/29/2025 - 21:59:59
Bid
Volume 		Ask
08/29/2025 - 21:59:59
Ask
Volume
46.58
-2.00 ( -4.12% )
46.55
8,700
46.60
16,800
More information
Analysis by TheScreener
29.08.2025
Evaluation Slightly negative  
Interest Weak  
Sensibility High  
Analysis date: 29.08.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 11.07.2025.
Interest
  Weak
Two stars since 18.07.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 20.06.2025 at a price of 29.31.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 11.07.2025.
4wk Rel Perf
  28.17%
 
The four-week dividend-adjusted overperformance versus SP500 is 28.17%.
Sensibility
  High
The stock has been on the high-sensitivity level since 04.02.2025.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.91%.
Mkt Cap in $bn
  5.99
With a market capitalization between $2 & $8bn, AVIDITY BIOSCIENCES is considered a mid-cap stock.
G/PE Ratio
  -0.68
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
  -12.31
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  -8.34%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  112
For 1% of index variation, the stock varies on average by 1.12%.
Correlation
  0.36
Stock movements are strongly independent of index variations.
Value at Risk
  30.11
The value at risk is estimated at USD 30.11. The risk is therefore 64.63%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  04.02.2025